Polycystic ovary syndrome.
Polycystic ovary syndrome comprises a group of chronic, progressive diseases of the female reproductive system. Clinical characteristics include disorders of ovulation and menstruation, hirsutism, infertility and obesity. Recommended treatment of the unacceptable manifestations includes the use of oral contraceptives or progestins. Fertility can often be achieved with clomiphene citrate and/or other agents. Rarely is surgical therapy indicated.
Chihal
H J
HJ
Baudier
M M
MM
D000728:Androgens / Q000097:blood; D002996:Clomiphene / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000627:therapeutic use; D003687:Dehydroepiandrosterone / Q000031:analogs & derivatives / Q000097:blood; D019314:Dehydroepiandrosterone Sulfate; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006628:Hirsutism / Q000209:etiology; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy / Q000209:etiology; D007986:Luteinizing Hormone / Q000097:blood; D008599:Menstruation Disturbances / Q000209:etiology; D010053:Ovary / Q000473:pathology; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D011372:Progestins / Q000627:therapeutic use; D012306:Risk; D014594:Uterine Neoplasms / Q000209:etiology
D000728:Androgens; D003276:Contraceptives, Oral; D011372:Progestins; D002996:Clomiphene; D003687:Dehydroepiandrosterone; D019314:Dehydroepiandrosterone Sulfate; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone